These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
442 related articles for article (PubMed ID: 30284433)
1. [COMPARATIVE EXPERIMENTAL EVALUATION OF THE EFFECTIVENESS OF MODERN PROBIOTICS, PREBIOTICS, SYNBIOTICS AND METABIOTICS FOR CORRECTION OF INTESTINAL MICROBIOCENOSIS IN ANIMALS WITH ANTIBIOTIC-ASSOCIATED DYSBIOSIS]. Chicherin IY; Pogorelsky IP; Lundovskikh IA; Darmov IV; Shabalina MR; Podvolotsky AN Eksp Klin Gastroenterol; 2016; (7):106-20. PubMed ID: 30284433 [TBL] [Abstract][Full Text] [Related]
2. Probiotics, Prebiotics, and Synbiotics in the Irritable Bowel Syndrome Treatment: A Review. Chlebicz-Wójcik A; Śliżewska K Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439821 [TBL] [Abstract][Full Text] [Related]
3. Probiotics, prebiotics, and synbiotics regulate the intestinal microbiota differentially and restore the relative abundance of specific gut microorganisms. Li C; Niu Z; Zou M; Liu S; Wang M; Gu X; Lu H; Tian H; Jha R J Dairy Sci; 2020 Jul; 103(7):5816-5829. PubMed ID: 32418689 [TBL] [Abstract][Full Text] [Related]
4. Rebuilding the Gut Microbiota Ecosystem. Gagliardi A; Totino V; Cacciotti F; Iebba V; Neroni B; Bonfiglio G; Trancassini M; Passariello C; Pantanella F; Schippa S Int J Environ Res Public Health; 2018 Aug; 15(8):. PubMed ID: 30087270 [TBL] [Abstract][Full Text] [Related]
5. [EFFECT OF POLYCOMPONENT PROBIOTICS ON THE COMPOSITION OF COLON MICROBIOCENOSIS DURING EXPERIMENTAL DYSBIOSIS]. Ageichenko AV; Kalutsky PV; Medvedeva OA; Korolev VA Zh Mikrobiol Epidemiol Immunobiol; 2015; (4):80-4. PubMed ID: 26470424 [TBL] [Abstract][Full Text] [Related]
6. Therapeutic interventions for gut dysbiosis and related disorders in the elderly: antibiotics, probiotics or faecal microbiota transplantation? Vemuri RC; Gundamaraju R; Shinde T; Eri R Benef Microbes; 2017 Apr; 8(2):179-192. PubMed ID: 28008784 [TBL] [Abstract][Full Text] [Related]
7. Probiotics, Prebiotics, Synbiotics, Postbiotics, and Obesity: Current Evidence, Controversies, and Perspectives. Vallianou N; Stratigou T; Christodoulatos GS; Tsigalou C; Dalamaga M Curr Obes Rep; 2020 Sep; 9(3):179-192. PubMed ID: 32472285 [TBL] [Abstract][Full Text] [Related]
8. Modulation of the gut microbiota: a focus on treatments for irritable bowel syndrome. Harris LA; Baffy N Postgrad Med; 2017 Nov; 129(8):872-888. PubMed ID: 28936910 [TBL] [Abstract][Full Text] [Related]
12. Antibiotic-Therapy-Induced Gut Dysbiosis Affecting Gut Microbiota-Brain Axis and Cognition: Restoration by Intake of Probiotics and Synbiotics. Dahiya D; Nigam PS Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834485 [TBL] [Abstract][Full Text] [Related]
13. Effects of Probiotics, Prebiotics, and Synbiotics on Human Health. Markowiak P; Śliżewska K Nutrients; 2017 Sep; 9(9):. PubMed ID: 28914794 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic advances in non-alcoholic fatty liver disease: A microbiota-centered view. Chen HT; Huang HL; Li YQ; Xu HM; Zhou YJ World J Gastroenterol; 2020 Apr; 26(16):1901-1911. PubMed ID: 32390701 [TBL] [Abstract][Full Text] [Related]
15. GUT MICROBIOTA, PREBIOTICS, PROBIOTICS, AND SYNBIOTICS IN MANAGEMENT OF OBESITY AND PREDIABETES: REVIEW OF RANDOMIZED CONTROLLED TRIALS. Barengolts E Endocr Pract; 2016 Oct; 22(10):1224-1234. PubMed ID: 27409822 [TBL] [Abstract][Full Text] [Related]
16. Probiotics, prebiotics and synbiotics for weight loss and metabolic syndrome in the microbiome era. Ferrarese R; Ceresola ER; Preti A; Canducci F Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7588-7605. PubMed ID: 30468509 [TBL] [Abstract][Full Text] [Related]
18. Gut microbiota: novel therapeutic target for nonalcoholic fatty liver disease. Suk KT; Kim DJ Expert Rev Gastroenterol Hepatol; 2019 Mar; 13(3):193-204. PubMed ID: 30791767 [TBL] [Abstract][Full Text] [Related]
19. Therapeutic methods of gut microbiota modification in colorectal cancer management - fecal microbiota transplantation, prebiotics, probiotics, and synbiotics. Kaźmierczak-Siedlecka K; Daca A; Fic M; van de Wetering T; Folwarski M; Makarewicz W Gut Microbes; 2020 Nov; 11(6):1518-1530. PubMed ID: 32453670 [TBL] [Abstract][Full Text] [Related]
20. A New Approach to Polycystic Ovary Syndrome: The Gut Microbiota. Yurtdaş G; Akdevelioğlu Y J Am Coll Nutr; 2020; 39(4):371-382. PubMed ID: 31513473 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]